Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Shin Poog Pharmaceutical Co., Ltd.

Home Clinical Trial Sponsors and OrganizationsShin Poog Pharmaceutical Co., Ltd.

Shin Poog Pharmaceutical Co., Ltd.

ACTIVE

Private

Also known as:

shin poong pharmaceutical co. ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

27

1 active

Approvals

25

Total approvals

Agencies

2

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

11

40.7%

Not Applicable

5

18.5%

Phase 1

5

18.5%

Phase 3

5

18.5%

Phase 4

1

3.7%

Trial Status Distribution

Completed

20

74.1%

Enrolling By Invitation

1

3.7%

Recruiting

2

7.4%

Terminated

1

3.7%

Unknown

3

11.1%

Clinical Trials

Trials sponsored by this organization (27)

Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care

Feb 2025852 participants

Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension

Enrolling By Invitation

Dec 2024252 participants

Efficacy and Safety of SPC1001 in Patients With Essential Hypertension

Jun 2024252 participants

Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis

Jun 2023297 participants

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Jul 202220 participants

Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension

Mar 2022253 participants

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

Jan 202260 participants

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

Oct 20211,807 participants

Page 1 of 4

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

22

Approvals

PHILIPPINES

Philippines FDA

3

Approvals

Recent Approvals

14 November 2024

06 October 2022

Ceftezole Sodium for Injection

Ceftezole Sodium for Injection

Cefazedone Sodium for Injection

Cefazedone Sodium for Injection

Cefazedone Sodium for Injection

Ceftezole Sodium for Injection

Cefazedone Sodium for Injection

Ceftezole Sodium for Injection

News

No news articles found

On this page

Overview
Clinical Trials27
Approvals25
News

Back to Organizations